biotech · Bile acid diarrhoea · Transthyretin cardiac amyloidosis · GLUE
Monte Rosa Therapeutics
Monte Rosa Therapeutics is a biotech organization headquartered in Boston, USA. It trades on NYSE under ticker GLUE. Primary therapeutic focus areas include Bile acid diarrhoea, Transthyretin cardiac amyloidosis, Lactati
Company details
- Status
- Public
- HQ
- Boston, USA
- Employees
- 213
- Programs
- 7
- Drugs
- 14
- Patents
- 72
Quick answer
Monte Rosa Therapeutics is a biotech organization headquartered in Boston, USA. It trades on NYSE under ticker GLUE. Primary therapeutic focus areas include Bile acid diarrhoea, Transthyretin cardiac amyloidosis, Lactation Suppressed, NSCLC, Brain Neoplasms, Malignant, Primary. NovaPharmaNews links 7 clinical program(s), 0 drug profile(s), and 72 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources. Pipeline phase mix: phase 2 (3), approved (2), phase 1 (2).
Company snapshot
Monte Rosa Therapeutics is a clinical-stage biotechnology company developing highly selective molecular glue degrader (MGD) medicines for patients living with serious diseases in the areas of oncology, autoimmune and inflammatory diseases, and more. Monta Rosa’s QuEEN™ (Quantitative and Engineered Elimination of Neosubstrates) discovery engine combines AI-guided chemistry, diverse chemical librari
- 7 active pipeline program(s) linked via ClinicalTrials.gov.
- 72 US patent(s) indexed to this assignee profile.
- 7 trial update(s) in the last 12 months.
Public regulatory, clinical, patent, and corporate records for Monte Rosa Therapeutics. Not investment advice.
Top assets
Lead pipeline drugs
- approved
- approved
- Marketed / approved
- Marketed / approved
Active clinical programs
- Phase 2
- Phase 2
- Phase 2
- Phase 1
Momentum
Proprietary activity score for Monte Rosa Therapeutics.
1 active signal
Signal breakdown
- Clinical trials
- Nova articles
- Patents filed
- FDA actions
- SEC filings
- Conference presentations
- Pipeline advances
Recent activity
Latest pipeline, patent, and corporate events for Monte Rosa Therapeutics.
- Clinical update
- Clinical update
- Clinical update
- Clinical update
- Clinical update
Quick answers
Common questions about this sponsor — for analysts and search.
-
What is Monte Rosa Therapeutics?
-
Is Monte Rosa Therapeutics publicly traded?
-
What drugs does Monte Rosa Therapeutics develop or market?
-
What are the latest developments for Monte Rosa Therapeutics?
-
What therapeutic areas does Monte Rosa Therapeutics focus on?
Therapeutic focus
Therapeutic area distribution
Pipeline concentration by therapeutic area from linked clinical programs.